Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0WEICA)
| ADC Name |
Pertuzumab-S239C-Compound (XV)
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
Pertuzumab-S239C Compound (XV)
Click to Show/Hide
|
|||||
| Organization |
Orum Therapeutics, Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1-2
|
|||||
| Structure |
|
|||||
| Antibody Name |
Pertuzumab-S239C
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (HER2)
|
Antigen Info | ||||
| Payload Name |
Pertuzumab-S239C-Compound (XV) payload
|
|||||
| Linker Name |
Pertuzumab-S239C-Compound (XV) linker
|
|||||